June 23, 2023 06:28 AM EDTUpdated 10:07 AM
Peer Review

Se­bas­t­ian Guth sharp­ens his fo­cus at Bay­er; As CD47 strug­gles per­sist, I-Mab ap­points CEO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Bay­er is re­fin­ing Se­bas­t­ian Guth’s role on June 30, nam­ing him se­nior Bay­er rep­re­sen­ta­tive and pres­i­dent of Bay­er US. Guth …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times